Minaris Regenerative Medicine

Hitachi Chemical Advanced Therapeutics Solutions (HCATS), apceth Biopharma GmbH, and Hitachi Chemical Co., Ltd. Regenerative Medicine are now operating under the joint name, Minaris Regenerative Medicine. The company remains a wholly owned subsidiary of Hitachi Chemical Co., Ltd., which has announced its name change to Show Denko Materials on October 1, 2020. Minaris Regenerative Medicine is a leading global contract development and manufacturing organization (CDMO) dedicated to the production of cell and gene therapy products. For more than 20 years, we have been offering clinical and commercial manufacturing services, development solutions, and technologies while providing outstanding quality and reliability. Our state-of-the-art facilities are located within the United States (New Jersey and California), Europe (Germany), and Asia (Japan) allow us to supply patients worldwide with life-changing therapies.